Temybric Ellipta
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Temybric Ellipta, covering 2022-11-24 to 2022-11-24. Get the full timeline:
Most recent: EMA Lapsed: Temybric Ellipta (fluticasone furoate;umeclidinium bromide;vilanterol trifenatate) — GlaxoSmithKline Trading Services Limited